Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0841
D

Lack of Policy and Oversight for Continuous Glucose Monitoring Device Use

Baltimore, Maryland Survey Completed on 07-24-2025

Penalty

Fine: $11,155
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility's Medical Director failed to ensure the adequate implementation of resident care interventions and policy review regarding the use of a continuous glucose monitoring device for a resident. Upon admission, the resident was prescribed a continuous glucose monitoring device to monitor blood glucose levels without finger sticks, which the resident preferred due to pain in the fingertips. However, the device was discontinued shortly after being ordered, despite the resident and family expressing dissatisfaction with reverting to finger sticks. Medical record review confirmed the device was ordered and used for approximately 2.5 days before being removed. Interviews with facility staff revealed that there was no existing policy for the use of continuous glucose monitoring devices, as the facility typically associated such devices with home settings. The Medical Director communicated to the provider that the device could not be used in the facility, but there was no formal or documented education provided to staff or other providers regarding this decision. Additionally, there was no documentation of a policy or procedure being developed for the use or non-use of such devices, nor any formal education following the Medical Director's awareness of the device's use in the facility.

An unhandled error has occurred. Reload 🗙